Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains

• Published in: The Journal of biological chemistry 1995-01, Vol.270 (1), p.287-295
• Main Authors: Körner, C, Nürnberg, B, Uhde, M, Braulke, T
• Format: Article
• Language: English
• Subjects: Adenosine Diphosphate Ribose - metabolism; Animals; Bordetella pertussis; Catalysis; Cytoplasm - metabolism; GTP Phosphohydrolases - metabolism; GTP-Binding Proteins - metabolism; Humans; Insulin-Like Growth Factor II - metabolism; L Cells - metabolism; Mannosephosphates - metabolism; Mice; Mutation; Pertussis Toxin; Phospholipids - metabolism; Receptor, IGF Type 2 - genetics; Receptor, IGF Type 2 - metabolism; Virulence Factors, Bordetella - metabolism
• ISSN: 0021-9258
• DOI: 10.1074/jbc.270.1.287

The binding of insulin-like growth factor II (IGF II) to the mannose 6-phosphate (M6P)/IGF II receptor has previously been reported to induce the activation of trimeric G(i)2 proteins by functional coupling to a 14-amino acid region within the cytoplasmic receptor domain (Nishimoto, I., Murayama, Y., Katada, T., Ui, M., and Ogata, E. (1989) J. Biol. Chem. 264, 14029-14038). In the present study, we examined further the potential functional coupling of G-proteins with the human M6P/IGF II receptor and mutant receptors lacking the proposed G-protein activator sequence. IGF II treatment of mouse L-cells expressing either wild type or mutant M6P/IGF II receptors failed to attenuate the pertussis toxin-catalyzed modification of a 40-kDa protein or enhance GTPase activity. In broken L-cell membranes expressing wild type or mutant M6P/IGF II receptors, 30 nM IGF II also failed to affect the pertussis toxin substrate activity. By using phospholipid vesicles reconstituted with human wild type or mutant M6P/IGF II receptors and pertussis toxin-sensitive G-proteins, no stimulation of GTP gamma S binding to or GTPase activity of G(i)2, G(o)1, or G(i)/G(o) mixtures were observed in response to 1 microM IGF II. Furthermore, in vesicles containing purified wild type M6P/IGF II receptors and monomeric G alpha o1 or G alpha i2 and beta gamma dimers no effects of IGF II on GTP gamma S binding could be detected. However, when vesicles reconstituted with M6P/IGF II receptors and G(i)2 proteins were incubated with 100 microM mastoparan GTP gamma S binding was stimulated and GTPase activity was increased significantly. These results indicate that the human M6P/IGF II receptor neither interacts with G-proteins in mouse L-cell membranes nor is coupled to G(i)2 proteins in phospholipid vesicles. This study suggests strongly that the M6P/IGF II receptor does not function in transmembrane signaling in response to IGF II.